PhRMA DTC Principles Compliance To Get Independent Panel Review In 2007
Executive Summary
PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress
You may also be interested in...
PhRMA’s DTC Principles: After Two Years, Still A Work In Progress
According to recent polling, Americans have a reasonably favorable opinion of direct-to-consumer advertising, but the pharmaceutical industry still sees potential trouble based on how the public perceives the practice
PhRMA’s DTC Principles: After Two Years, Still A Work In Progress
According to recent polling, Americans have a reasonably favorable opinion of direct-to-consumer advertising, but the pharmaceutical industry still sees potential trouble based on how the public perceives the practice
Pfizer’s Lipitor Ad Campaign Is A Cautionary Tale For Industry
Controversy surrounding Pfizer's direct-to-consumer advertisements for Lipitor spotlight the inherent risks manufacturers continue to face when launching ad campaigns